220 results
Page 10 of 11
424B3
cfl61 ojq
16 Apr 15
Prospectus supplement
12:00am
8-K
EX-99.1
6l4gakeg1cytx23
23 Feb 15
Other Events
12:00am
424B3
bwu65
23 Feb 15
Prospectus supplement
12:00am
424B3
hedhq2c1i8os1hq951nm
9 Feb 15
Prospectus supplement
12:00am
424B3
9xa36 ijrmnm4lyrum
12 Dec 14
Prospectus supplement
12:00am
424B3
d3x0 e9o17
18 Nov 14
Prospectus supplement
12:00am
8-K
EX-99.1
1j8kx5z
18 Nov 14
Arch Therapeutics Reports Positive Preclinical Data from Study of AC5
12:00am
424B3
jssxnsx
6 Nov 14
Prospectus supplement
12:00am
424B3
96d2k50 ljwit
8 Sep 14
Prospectus supplement
12:00am
8-K
r2pec6ork1p vo
8 Sep 14
Arch Therapeutics Announces Positive Preclinical Data from an Independent Study of AC5 Surgical Hemostatic Device™ in Animals on Blood Thinners
12:00am
8-K
EX-99.1
dps9rr56i
8 Sep 14
Arch Therapeutics Announces Positive Preclinical Data from an Independent Study of AC5 Surgical Hemostatic Device™ in Animals on Blood Thinners
12:00am
424B3
o8m22rhgp5e9hkw sdo
6 Aug 14
Prospectus supplement
12:00am
424B3
v34cqav chh9yh77jui
8 Jul 14
Prospectus supplement
12:00am
8-K
EX-10.1
36d715
7 Jul 14
Arch Therapeutics Appoints Richard Davis as Chief Financial Officer
12:00am